VIVS Insider Transactions
41 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 1–41; provenance stays internal.
VIVS insiders transaction timeline
PurchaseSale
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| Gobel David | Director | 2025-11-17 | Sale | 3,266.0 | $2.24 |
| Gobel David | Director | 2023-11-15 | Sale | 19,607.0 | $1.62 |
| Gobel David | Director | 2021-11-19 | Sale | 145.0 | $5.29 |
| Cohen Douglas Jay | Director | 2021-08-17 | Purchase | 1,000.0 | $6.72 |
| Cohen Douglas Jay | Director | 2021-08-17 | Purchase | 1,000.0 | $6.74 |
| Cohen Douglas Jay | Director | 2021-08-17 | Purchase | 8,750.0 | $6.72 |
| Hughes Steven George | Chief Medical Officer | 2019-08-16 | Sale | 22,230.0 | $0.29 |
| Presnell Sharon Collins | Chief Scientific Officer | 2018-11-08 | Sale | 40,000.0 | $1.27 |
| Murphy Keith | Other | 2017-11-24 | Purchase | 200,500.0 | $1.49 |
| Murphy Keith | Other | 2017-11-22 | Purchase | 135,000.0 | $1.5 |
| Murphy Keith | Chairman, CEO and President | 2017-02-09 | Sale | 25,000.0 | $3.68 |
| Murphy Keith | Chairman, CEO and President | 2017-01-24 | Sale | 20,100.0 | $3.5 |
| Murphy Keith | Chairman, CEO and President | 2017-01-23 | Sale | 4,900.0 | $3.51 |
| Murphy Keith | Chairman, CEO and President | 2016-12-14 | Sale | 50,000.0 | $3.72 |
| David Eric | CSO & EVP Pre-Clinical Dev | 2016-08-05 | Sale | 20,000.0 | $4.55 |
| Baltera Robert Jr. | Director | 2015-09-21 | Sale | 6,000.0 | $4.03 |
| GLOVER JAMES T | Director | 2015-08-13 | Purchase | 10,000.0 | $2.8 |
| Murphy Keith | Chairman, CEO and President | 2015-08-12 | Purchase | 20,000.0 | $2.56 |
| MICHAELS BARRY D | Chief Financial Officer | 2014-12-30 | Sale | 10,500.0 | $7.5 |
| David Eric | Chief Strategy Officer | 2014-12-30 | Sale | 16,300.0 | $7.56 |
| MICHAELS BARRY D | Chief Financial Officer | 2014-12-29 | Sale | 4,500.0 | $7.5 |
| David Eric | Chief Strategy Officer | 2014-12-29 | Sale | 3,700.0 | $7.5 |
| Presnell Sharon Collins | EVP, Research & Dev & CTO | 2014-10-06 | Sale | 50,000.0 | $6.11 |
| David Eric | Chief Strategy Officer | 2014-09-12 | Sale | 30,000.0 | $7.3 |
| Renard Michael | EVP of Commercial Operations | 2014-02-21 | Sale | 10,000.0 | $10.65 |
| Murphy Keith | Chairman, CEO and President | 2014-02-18 | Sale | 100,000.0 | $9.82 |
| Renard Michael | EVP of Commercial Operations | 2014-01-29 | Sale | 30,000.0 | $9.93 |
| Renard Michael | EVP of Commercial Operations | 2014-01-27 | Sale | 10,000.0 | $8.92 |
| Murphy Keith | Chairman, CEO and President | 2014-01-21 | Sale | 100,000.0 | $10.86 |
| MICHAELS BARRY D | Chief Financial Officer | 2013-12-16 | Sale | 85,353.0 | $9.07 |
| Murphy Keith | Chairman, CEO and President | 2013-12-10 | Sale | 100,000.0 | $10.08 |
| Murphy Keith | Chairman, CEO and President | 2013-11-13 | Sale | 100,000.0 | $9.64 |
| David Eric | Chief Strategy Officer | 2013-11-13 | Sale | 16,470.0 | $10.39 |
| Murphy Keith | Chairman, CEO and President | 2013-10-18 | Sale | 30,000.0 | $6.63 |
| Murphy Keith | Chairman, CEO and President | 2013-10-16 | Sale | 70,000.0 | $5.76 |
| David Eric | Chief Strategy Officer | 2013-10-10 | Sale | 3,530.0 | $5.66 |
| David Eric | Chief Strategy Officer | 2013-10-07 | Sale | 63,000.0 | $5.86 |
| Presnell Sharon Collins | EVP, Research & Dev & CTO | 2013-10-02 | Sale | 75,000.0 | $5.64 |
| Presnell Sharon Collins | EVP, Research & Dev & CTO | 2013-08-12 | Sale | 75,000.0 | $5.6 |
| MICHAELS BARRY D | Chief Financial Officer | 2012-03-16 | Purchase | 10,000.0 | $1.0 |
| MICHAELS BARRY D | Chief Financial Officer | 2012-03-16 | Purchase | 10,000.0 | $1.0 |